You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma

  • Technology appraisal guidance
  • Reference number: TA226
  • Published:  22 June 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma (PDF 61 KB)

    Published:
    22 June 2011
  • Gwybodaeth i'r cyhoedd (Word 328 KB)

    Published:
    31 May 2012
Back to top